These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14018173)

  • 1. Immunization of newborn children with living oral trivalent poliovirus vaccine.
    CAMPILLO-SAINZ C; ORNELAS HERNANDEZ A; DE MUCHA MACIAS J; NAVA SE
    J Bacteriol; 1962 Sep; 84(3):446-50. PubMed ID: 14018173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Surveillance of immunization effectiveness and titer of type Ⅰ and type Ⅲ polio vaccine in Beijing before and after the adjustment of immunization strategy in 2012-2018].
    Li J; Zhang ZJZ; Pan JB; Zhang HR; Li RQ; Li MZ; Lu L; Huang F; Wu J
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Jul; 54(7):779-783. PubMed ID: 32842302
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunogenicity and safety evaluation of bivalent types 1 and 3 oral poliovirus vaccine by comparing different poliomyelitis vaccination schedules in China: A randomized controlled non-inferiority clinical trial.
    Qiu J; Yang Y; Huang L; Wang L; Jiang Z; Gong J; Wang W; Wang H; Guo S; Li C; Wei S; Mo Z; Xia J
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-10. PubMed ID: 28362135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
    Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
    Hotta C; Ogawa T; Shirasawa H
    Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of the Spanish National Campaign of oral vaccination polio 1963-1964: virological and epidemiological study].
    Pérez Gallardo F; Valenciano Clavel L; Gabriel y Galán J
    Rev Esp Salud Publica; 2013; 87(5):523-40. PubMed ID: 24322289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating vaccine-derived poliovirus type 2 outbreak in Democratic Republic of Congo 2011-2012].
    Bazira L; Coulibaly T; Mayenga M; Ncharre C; Yogolelo R; Mbule A; Moudzeo H; Lwamba P; Mulumba AW; Cabore J
    Bull Soc Pathol Exot; 2015 Oct; 108(4):235-41. PubMed ID: 26288132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
    Sarnquist C; Holubar M; García-García L; Ferreyra-Reyes L; Delgado-Sánchez G; Cruz-Hervert LP; Montero-Campos R; Altamirano J; Purington N; Boyle S; Modlin J; Ferreira-Guerrero E; Canizales-Quintero S; Díaz Ortega JL; Desai M; Maldonado YA
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S115-S120. PubMed ID: 30376084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
    Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
    Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review.
    Bandyopadhyay AS; Modlin JF; Wenger J; Gast C
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S35-S41. PubMed ID: 30376081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoprophylaxis of poliomyelitis in Ukraine with the use of inactivated vaccine].
    Frolov AF; Sel'nikova OP; Zadorozhnaia VI; Moiseeva AV; Demchishina IV; Bondarenko VI; Zubkova NL; Doan SI; Buraia TA
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (1):49-53. PubMed ID: 15773400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin).
    Dong DX; Hu XM; Liu WJ; Li JS; Jin YC; Tan SG; Chen TQ; Fu JZ; Niu BY; Yu HM
    Bull World Health Organ; 1986; 64(6):853-60. PubMed ID: 3493854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on immunization of polio vaccine. I. Observation on an improved immunization schedule].
    Su W
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):281-3. PubMed ID: 1664295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MASS IMMUNIZATION OF CHILDREN WITH ORAL, TRIVALENT POLIOVIRUS VACCINE (LEDERLE STRAINS).
    SERPA-FLOREZ F; MALDONADO-ROMERO D; ARGUELLO-PINZON A; BAHAMON-SOTO A; PINEROS-BERNAL H
    Pediatrics; 1964 Jun; 33():878-86. PubMed ID: 14169632
    [No Abstract]   [Full Text] [Related]  

  • 19. Early immunization of neonates with trivalent oral poliovirus vaccine.
    Weckx LY; Schmidt BJ; Herrmann AA; Miyasaki CH; Novo NF
    Bull World Health Organ; 1992; 70(1):85-91. PubMed ID: 1314711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.